Qué cambió
Operaciones y participacionesDanaher Corporation reveló una serie de operaciones con información privilegiada realizadas en noviembre de 2026, incluidas ventas de acciones, ejercicios de opciones y concesiones de capital. Las actividades incluyeron la notificación de una propuesta de venta de 23.010 acciones por parte de un exdirectivo y operaciones rutinarias de la alta dirección para retener acciones destinadas al pago de impuestos.

Qué cambióDanaher aumentó sus ingresos del tercer trimestre de 2026 un 8,5 %, hasta 6,6 mil millones de $, y elevó su previsión de beneficio anual. El beneficio por acción ajustado subió un 11,5 %, hasta 2,11 $.

Qué cambióJulie Sawyer Montgomery стала президентом і генеральним директором Данахера 1 жовтня 2026 р.

Historial de la empresa
Octubre 2026
DANAHER CORP /DE/: 12 recorded developments from 1 official source in 2026-10.
- 2026-10-21: Revenue (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), quarter 2026-06-27 to 2026-09-25: 6,554,000,000 USD (6.6 billion; 6,554 million); same period a year earlier (2025-06-28 to 2025-09-26): 6,053,000,000 USD (6.1 billion; 6,053 million); change +8.3% Fuente
- 2026-10-21: Revenue (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), year to date 2026-01-01 to 2026-09-25: 18,770,000,000 USD (18.8 billion; 18,770 million); same period a year earlier (2025-01-01 to 2025-09-26): 17,730,000,000 USD (17.7 billion; 17,730 million); change +5.9% Fuente
- 2026-10-21: Gross profit (us-gaap:GrossProfit), quarter 2026-06-27 to 2026-09-25: 3,837,000,000 USD (3.8 billion; 3,837 million); same period a year earlier (2025-06-28 to 2025-09-26): 3,523,000,000 USD (3.5 billion; 3,523 million); change +8.9% Fuente
- 2026-10-21: Gross profit (us-gaap:GrossProfit), year to date 2026-01-01 to 2026-09-25: 11,039,000,000 USD (11 billion; 11,039 million); same period a year earlier (2025-01-01 to 2025-09-26): 10,557,000,000 USD (10.6 billion; 10,557 million); change +4.6% Fuente
- 2026-10-21: Operating income (us-gaap:OperatingIncomeLoss), quarter 2026-06-27 to 2026-09-25: 1,245,000,000 USD (1.2 billion; 1,245 million); same period a year earlier (2025-06-28 to 2025-09-26): 1,154,000,000 USD (1.2 billion; 1,154 million); change +7.9% Fuente
- 2026-10-21: Operating income (us-gaap:OperatingIncomeLoss), year to date 2026-01-01 to 2026-09-25: 3,716,000,000 USD (3.7 billion; 3,716 million); same period a year earlier (2025-01-01 to 2025-09-26): 3,188,000,000 USD (3.2 billion; 3,188 million); change +16.6% Fuente
- 2026-10-21: Net income (us-gaap:NetIncomeLoss), quarter 2026-06-27 to 2026-09-25: 1,235,000,000 USD (1.2 billion; 1,235 million); same period a year earlier (2025-06-28 to 2025-09-26): 908,000,000 USD (908 million); change +36% Fuente
- 2026-10-21: Net income (us-gaap:NetIncomeLoss), year to date 2026-01-01 to 2026-09-25: 3,134,000,000 USD (3.1 billion; 3,134 million); same period a year earlier (2025-01-01 to 2025-09-26): 2,417,000,000 USD (2.4 billion; 2,417 million); change +29.7% Fuente
- 2026-10-21: Research and development expense (us-gaap:ResearchAndDevelopmentExpense), quarter 2026-06-27 to 2026-09-25: 433,000,000 USD (433 million); same period a year earlier (2025-06-28 to 2025-09-26): 378,000,000 USD (378 million); change +14.6% Fuente
- 2026-10-21: Research and development expense (us-gaap:ResearchAndDevelopmentExpense), year to date 2026-01-01 to 2026-09-25: 1,232,000,000 USD (1.2 billion; 1,232 million); same period a year earlier (2025-01-01 to 2025-09-26): 1,160,000,000 USD (1.2 billion; 1,160 million); change +6.2% Fuente
- 2026-10-21: Operating cash flow (us-gaap:NetCashProvidedByUsedInOperatingActivities), year to date 2026-01-01 to 2026-09-25: 4,742,000,000 USD (4.7 billion; 4,742 million); same period a year earlier (2025-01-01 to 2025-09-26): 4,299,000,000 USD (4.3 billion; 4,299 million); change +10.3% Fuente
- 2026-10-21: Capital expenditure (us-gaap:PaymentsToAcquirePropertyPlantAndEquipment), year to date 2026-01-01 to 2026-09-25: 761,000,000 USD (761 million); same period a year earlier (2025-01-01 to 2025-09-26): 785,000,000 USD (785 million); change -3.1% Fuente
Julio 2026
Danaher Corp reported second quarter 2026 financial results and continues the integration of Masimo.
- For the three-month period ended June 26, 2026, the Company reported that overall revenues and core sales increased 5.5% and 3.0%, respectively, compared to 2025, while price decreases of 0.5% negatively impacted sales growth. Fuente
- The Company is engaged in the integration of Masimo, an acquisition for which the Company incurred debt to finance a portion of the purchase price. Fuente
- For the six-month period ended June 26, 2026, the Company’s overall revenues and core sales increased 4.5% and 2.0%, respectively, compared to the comparable period of 2025. Fuente
Los registros mensuales los redacta la IA a partir de los informes y fuentes oficiales verificados de cada mes (en inglés, tal como se extrajeron), y cada línea enlaza su fuente; las líneas argumentales agrupan hechos relacionados entre análisis mediante embeddings vectoriales (Amazon Titan Text Embeddings V2). Contexto provisional, no es asesoramiento de inversión.
Comparables del sector
Comparación con 36 empresas seguidas en Salud (mediana de ingresos +7,2% a/a), según datos XBRL de la SEC.
| Empresa | Últimos ingresos | Ingresos a/a | Margen operativo |
|---|
| Danaher Corp DHR | 6,6 mil M $ | +8,3% | 19,0% |
| Unitedhealth Group Inc UNH | 113 mil M $ | -0,4% | 5,8% |
| Mckesson Corp MCK | 111 mil M $ | +7,6% | 1,4% |
| CVS Health Corp CVS | 108 mil M $ | +5,4% | 3,3% |
| Cigna Group CI | 73,7 mil M $ | +5,6% | 3,3% |
| Cardinal Health Inc CAH | 67,5 mil M $ | +5,5% | 1,1% |
| Elevance Health, Inc. ELV | 51,4 mil M $ | +1,4% | 2,5% |
Último periodo reportado por empresa en SEC CompanyFacts (XBRL). Los calendarios fiscales pueden diferir.
Cambios en los factores de riesgo
El 10-Q del 21 de octubre de 2026 comparado con el 10-Q del 21 de julio de 2026: párrafos de riesgo añadidos o eliminados, citados tal como se presentaron. SEC
Añadidos (18)
- efficiency and quality and effectively address the demands of an increasingly regulated global environment and the evolving trade environment. The Company is making significant investments, organically and through acquisitions and investments, to address the rapid pace of technological change and increasing demand for automation in its served markets and to position its manufacturing, research and development and customer-facing resources to be responsive to the Company’s customers throughout the world and improve the efficiency of the Company’s operations.
- In addition to the Masimo Acquisition, during the three and nine-month periods ended September 25, 2026, the Company acquired one business for total upfront consideration of $37 million in cash and $79 million of deferred consideration. The business acquired complements existing units of the Company’s Life Sciences segment. The Company preliminarily recorded an aggregate of $26 million of goodwill related to this acquisition and $144 million of identifiable intangible assets, of which a majority related to developed technology intangible assets. The annual sales of this business in its last…
- •the impact of tariff refunds received by the Company and returned (or expected to be returned) to customers.
Eliminados (6)
- the Company and its peers and can also obscure underlying business trends and make comparisons of long-term performance difficult. The Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company’s larger acquisitions) if it determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period.
- | June 26, 2026 | | June 27, 2025 | | June 26, 2026 | | June 27, 2025
- ($ in millions) | June 26, 2026 | | June 27, 2025 | | June 26, 2026 | | June 27, 2025
Detectado comparando los dos informes párrafo a párrafo, sin IA. Un riesgo nuevo o eliminado no es por sí mismo señal de problemas.
Hechos de gobierno corporativo
Documentos sobre cómo se dirige la empresa: cambios de auditor, reformulaciones, cambios en la dirección, informes tardíos, exclusiones de cotización, participaciones del Schedule 13D y cartas de la SEC, de la más reciente a la más antigua.
| Fecha | Hecho | Declaración |
|---|
| 13 de octubre de 2026 | Salida o nombramiento de un consejero o directivo (8-K punto 5.02) | 8-K |
| 30 de septiembre de 2026 | Exclusión de cotización de un valor (Form 25) | 25-NSE |
| 3 de agosto de 2026 | Salida o nombramiento de un consejero o directivo (8-K punto 5.02) | 8-K |
Tal como se presentó a la SEC, leído por código. Una carta de comentarios forma parte de la revisión habitual de la SEC y no implica por sí sola un problema; el punto 5.02 incluye nombramientos y salidas; el Form 25 puede referirse a un bono u otra clase de valores.
Grandes fondos (13F)
| Fondo | Acciones | Valor | Cambio en acciones | Trimestre |
|---|
| BlackRock | 53.976.143 | $11.958.414.464 | -2,0% | T3 2026 |
| Fidelity (FMR) | 38.707.539 | $8.575.655.214 | +31,0% | T3 2026 |
| State Street | 28.547.173 | $6.335.876.761 | +0,3% | T3 2026 |
| Capital Research Global Investors | 15.995.884 | $3.544.121.287 | +47,9% | T3 2026 |
| Geode Capital Management | 14.384.878 | $3.171.976.288 | +0,7% | T3 2026 |
| Norges Bank (Norway's sovereign fund) | 9.537.906 | $1.816.780.335 | — | T2 2026 |
| Wellington Management | 6.588.621 | $1.459.708.983 | -59,6% | T3 2026 |
| Tiger Global Management | 1.268.800 | $281.102.640 | +178,2% | T3 2026 |
| Millennium Management | 1.246.331 | $276.124.633 | -41,8% | T3 2026 |
| Citadel Advisors | 725.217 | $160.671.827 | -23,2% | T3 2026 |
| Renaissance Technologies | 760.636 | $144.885.945 | +12,1% | T2 2026 |
| Third Point (Dan Loeb) | 540.000 | $102.859.200 | +2,9% | T2 2026 |
| D. E. Shaw & Co. | 461.715 | $102.292.958 | +12,1% | T3 2026 |
| Bridgewater Associates | 396.238 | $87.786.529 | +1442,7% | T3 2026 |
| Two Sigma Investments | 82.018 | $18.171.088 | -81,9% | T3 2026 |
De los informes trimestrales 13F-HR de los grandes fondos que seguimos, tal como se presentaron. Los fondos informan hasta 45 días después del cierre del trimestre, por lo que las posiciones pueden haber cambiado. Cambio: frente al trimestre anterior del mismo fondo. No es una recomendación.